foxo4 dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect FOXO4 DRI 10mg vial Description RCpeptides FOXO4 DRI Vial 10mg Stemcode Peptides Buy FOXO4 DRI UK 98% Purity Next Day Dispatch
Pay in 4 interest-free payments of $6.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




